You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 65 No. 3, March 2008 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  Original Contribution
 •Online Features
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (17)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Neurology
 •Neurogenetics
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

The G13513A Mutation in the ND5 Gene of Mitochondrial DNA as a Common Cause of MELAS or Leigh Syndrome

Evidence From 12 Cases

Sara Shanske, PhD; Jorida Coku, BS; Jiesheng Lu, MD; Jaya Ganesh, MD; Sindu Krishna, PhD; Kurenai Tanji, MD; Eduardo Bonilla, MD; Ali B. Naini, PhD; Michio Hirano, MD; Salvatore DiMauro, MD

Arch Neurol. 2008;65(3):368-372.

Background  The number of molecular causes of MELAS (a syndrome consisting of mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes) and Leigh syndrome (LS) has steadily increased. Among these, mutations in the ND5 gene (OMIM 516005) of mitochondrial DNA are important, and the A13513A change has emerged as a hotspot.

Objective  To describe the clinical features, muscle pathological and biochemical characteristics, and molecular study findings of 12 patients harboring the G13513A mutation in the ND5 gene of mitochondrial DNA compared with 14 previously described patients with the same mutation.

Design  Clinical examinations and morphological, biochemical, and molecular analyses.

Setting  Tertiary care university hospital and molecular diagnostic laboratory.

Patients  Three patients had the typical syndrome features of MELAS; the other 9 had typical clinical and radiological features of LS.

Results  Family history suggested maternal inheritance in a few cases; morphological studies of muscle samples rarely showed typical ragged-red fibers and more often exhibited strongly succinate dehydrogenase–reactive blood vessels. Biochemically, complex I deficiency was inconsistent and generally mild. The mutation load was relatively high in the muscle and blood specimens.

Conclusion  The G13513A mutation is a common cause of MELAS and LS, even in the absence of obvious maternal inheritance, pathological findings in muscle, or severe complex I deficiency.


Author Affiliations: Departments of Neurology (Drs Shanske, Lu, Krishna, Bonilla, Naini, Hirano, and DiMauro and Ms Coku) and Pathology (Drs Tanji and Bonilla), Columbia University Medical Center, New York, New York; and Section of Biochemical Genetics, The Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia (Dr Ganesh).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Mitochondrial ND5 mutations mimicking brainstem tectal glioma
Rio et al.
Neurology 2010;75:93-93.
FULL TEXT  

A 41-year-old woman with progressive leg weakness and numbness, dizziness, and myalgia
DiMauro et al.
Neurology 2009;72:1262-1268.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.